Tag: TEVAR
Kevin Mani
“We need to continue to build the scientific evidence base for what we do,” Kevin Mani (Uppsala, Sweden) tells Vascular News, underlining what he...
Gore announces first commercial implant of Gore Tag thoracic branch endoprosthesis...
Gore has announced the first commercial use of the Gore Tag thoracic branch endoprosthesis (TBE) in Canada.
The news came as Canadian government health authority...
Thoraco-aortic surgery set for shift in practice with European launch of...
This advertorial, sponsored by Gore, is only available in selected countries and geographies.
Following the European launch of the recently CE-marked GORE TAG Thoracic...
Study finds no correlation between TEVAR timing and uncomplicated type B...
With proper patient selection, short-term outcomes of thoracic endovascular aortic repair (TEVAR) in acute uncomplicated acute type B aortic dissection (uTBAD) are similar irrespective...
Shockwave Medical announces US launch of new peripheral IVL catheter
Shockwave Medical today announced the full US commercial availability of the Shockwave L6 peripheral intravascular lithotripsy (IVL) catheter following clearance by the US Food...
Vivasure Medical announces FDA IDE approval to initiate US pivotal study
Vivasure Medical has announced that the US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to advance the company’s PATCH...
Shape Memory Medical announces first patient treated in EMBO postmarket surveillance...
Shape Memory Medical has announced the first patient treated in Germany as part of the EMBO postmarket surveillance registry (EMBO-PMS), the company’s prospective, multicentre...
CX Aortic Vienna: Presenters advocate for patient-tailored approach in thoracoabdominal procedures
Day three of CX Aortic Vienna Digital Edition (24–26 October) gave airtime to risk prediction and management for thoracoabdominal aortic aneurysm (TAAA) procedures. Presentations...
Systemic heparin during TEVAR deemed safe for selected traumatic brain injury...
The use of systemic heparin during thoracic endovascular aneurysm repair (TEVAR) for blunt thoracic aortic injuries (BTAI) appears to be safe in selected patients...
Vivasure Medical announces Series D financing to advance portfolio of PerQseal...
Vivasure Medical has announced the closing of the first tranche of €22 million (US$23 million) as part of its Series D financing round that...
Gore receives FDA approval of Gore Tag thoracic branch endoprosthesis for...
Gore recently announced that the US Food and Drug Administration (FDA) has approved the Gore Tag thoracic branch endoprosthesis (TBE) for the endovascular repair...
CX 2022 highlights new data in the vascular world
Anticipation is building for the Charing Cross International Symposium 2022 (26–28 April, London, UK, in person and virtual), which this year will address some...
Study suggests more proximal landing zone is preferred for TEVAR of...
A review evaluating the results of thoracic endovascular aortic repair (TEVAR) following acute type B aortic dissection suggests most patients with acute type B...
GORE® ACTIVE CONTROL System: “A system for the masses”
NOTE: This video is ONLY available to watch in selected countries and geographies
Robert Rhee (New York, USA) moderates a Charing Cross 2021 webinar–A...
RelayPro US transection pivotal study completes enrolment
Terumo Aortic has announced completion of enrolment of the RelayPro traumatic injury (RelayPro-T) investigational device exemption (IDE) study in the USA. RelayPro is a...
Terumo Aortic announces mid-term results with real-world use of the RelayPlus...
Terumo Aortic has announced the midterm results from the RelayPlus thoracic stent graft system post-approval study, revealing low operative mortality and morbidity—supporting its use...
Expanding treatment possibilities in TEVAR
NOTE: This supplement is only available to read in selected countries and geographies
In this supplement, sponsored by Medtronic:
Fabio Verzini discusses his clinical experience...
“No evidence” to suggest spinal cord injury is decreased by prophylactic...
Cerebrospinal fluid (CSF) drainage is a key component in the treatment of spinal cord injury but the evidence that prophylactic drainage decreases such injury...
Medtronic presents one-year Valiant Navion, four-year ANCHOR registry clinical outcomes
Medtronic has announced one-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and four-year clinical outcomes from the ANCHOR...
SVS 2019: Elderly patients should not be denied TEVAR based on...
Ali Azizzadeh (Los Angeles, USA) talks to BLearning at SVS 2019 (Society for Vascular Surgery, 12–15 June, Washington DC, USA) about his recent move from Houston, Texas to...
First US patient receives Gore TAG conformable thoracic stent graft with...
Gore has announced the first US implant of its Gore TAG conformable thoracic stent graft with ACTIVE CONTROL system. The successful procedure was performed...
Multicentre dataset reveals the added value of diffusion-weighted imaging in TEVAR...
Novel data from the Stroke from Thoracic Endovascular Procedures (STEP) study has provided insight into current practice of thoracic endovascular aortic repair (TEVAR), and...
Gore introduces GORE TAG Conformable Thoracic Stent Graft with reduced profiles...
Gore has introduced reduced profiles for the most commonly used diameters of the GORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System. The reduced profile...
Valiant Navion thoracic stent graft receives FDA approval
The US Food and Drug Administration (FDA) has approved Valiant Navion thoracic stent graft system (Medtronic) for the minimally invasive repair of all lesions...
Tilo Kölbel: The Stroke from Thoracic Endovascular Procedures (STEP) collaboration
Tilo Kölbel (University Heart Center Hamburg, Germany) talks about the findings of the STEP collaboration, and why endovascular procedure operators perhaps are "not the...
Final five-year results from the STABLE I feasibility study presented at...
Five-year follow-up data from STABLE I, a global feasibility study of the Zenith Dissection Endovascular stent (Cook Medical), were presented by Joseph Lombardi (Cooper...
STEP seeks to advance patient safety after TEVAR
Stroke is a major concern following TEVAR (thoracic endovascular aortic repair) and Charing Cross delegates heard the results from a collaborative study that pooled...
When to consider TEVAR in uncomplicated TBAD
A new study suggests thoracic endovascular aortic repair (TEVAR) may be appropriate in uncomplicated Type B aortic dissection (TBAD) based on several anatomic criteria...
First patient enrolled in registry for the Gore TAG Conformable stent...
Gore has announced the first patient enrolment in its post-market European registry for the Gore TAG Conformable Thoracic Stent Graft with Active Control System, following...
Castor branched aortic stent graft gains CFDA approval
The Castor branched aortic stent graft system, developed by MicroPort Endovascular, has obtained the regulatory approval from China Food and Drug Administration (CFDA), formally...
Endologix announces collaboration agreements with Japan Lifeline for development and commercialisation...
Endologix has signed a joint research and development agreement, as well as an exclusive distribution agreement, with Japan Lifeline (JLL) pertaining to the development...
First-in-human use TEVAR of Gore TAG thoracic stent graft with Active...
Gore has announced the first patient implant of the TAG conformable thoracic stent graft with Active Control system after the receipt of CE mark...
Increased mortality in females after TEVAR
It is well known that women have worse outcomes following treatment for abdominal aortic aneurysms, but a recent study finds that the results are...
Women face higher mortality following TEVAR for intact descending thoracic aortic...
Even after adjusting for differences in age and comorbidities, female patients have higher perioperative mortality and lower long-term survival after thoracic endovascular aneurysm repair...
Acute Dissections Symposium: “The Great Masquerader”
The best management of type B aortic dissection is an ongoing debate. In April 2016, W. L. Gore & Associates held a two-day symposium...
Valiant Captivia stent graft shows 90% freedom from dissection-related mortality at...
The Valiant Captivia thoracic stent graft system (Medtronic) has demonstrated freedom from all-cause mortality of 79.4% and freedom from dissection-related mortality of 90% at...
Predicting type B aortic dissection outcomes when the patient arrives
Stanford type B aortic dissection carries a better prognosis compared with type A dissection and 90% of patients survive to hospital discharge. The management...
